ORTX
$16.7
Revenue | $6.3Mn |
Net Profits | $-35.32Mn |
Net Profit Margins | -560.44% |
ORCHARD THERAPEUTICS PLC’s revenue jumped 9.09% since last year same period to $6.3Mn in the Q3 2023. On a quarterly growth basis, ORCHARD THERAPEUTICS PLC has generated -13.84% fall in its revenue since last 3-months.
ORCHARD THERAPEUTICS PLC’s net profit jumped 25.75% since last year same period to $-35.32Mn in the Q3 2023. On a quarterly growth basis, ORCHARD THERAPEUTICS PLC has generated -186.98% fall in its net profits since last 3-months.
ORCHARD THERAPEUTICS PLC’s net profit margin jumped 31.93% since last year same period to -560.44% in the Q3 2023. On a quarterly growth basis, ORCHARD THERAPEUTICS PLC has generated -233.07% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.31 |
EPS Estimate Current Year | -1.31 |
ORCHARD THERAPEUTICS PLC’s earning per share (EPS) estimates for the current quarter stand at -1.31 - a -74.67% fall from last quarter’s estimates.
ORCHARD THERAPEUTICS PLC’s earning per share (EPS) estimates for the current year stand at -1.31.
Earning Per Share (EPS) | -1.5 |
Return on Assets (ROA) | -0.29 |
Return on Equity (ROE) | -0.72 |
ORCHARD THERAPEUTICS PLC’s earning per share (EPS) jumped 59.46% since last year same period to -1.5 in the Q3 2023. This indicates that the ORCHARD THERAPEUTICS PLC has generated 59.46% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. ORCHARD THERAPEUTICS PLC’s return on assets (ROA) stands at -0.29.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. ORCHARD THERAPEUTICS PLC’s return on equity (ROE) stands at -0.72.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-13 | -0.75 | -1.5 | -100% |
2023-08-10 | -1.39 | -0.07 | 94.96% |
2023-05-15 | -1.66 | -0.12 | 92.77% |